Rockefeller Capital Management L.P. Avrobio, Inc. Transaction History

Rockefeller Capital Management L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $1,844 - $5,777	-1,430 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $87,009 - $152,581	-25,220 Reduced 94.63%	1,430 $5,000
Q1 2020 May 12, 2020	BUY	$10.08 - $27.21 $268,632 - $725,146	26,650 New	26,650 $415,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.